News
With a Trump-driven reduction of nearly 2,000 employees, agency officials view artificial intelligence as a way to speed ...
Artificial intelligence (AI) already helps clinicians to make diagnoses, triage critical cases and transcribe clinical notes ...
Aortic Stenosis is a Serious and Widespread Condition; The AI-ECG Algorithm Offers a Powerful Diagnostic Solution Designed ...
The U.S. FDA reported the launch of its in-house generative AI (GenAI) tool, dubbed Elsa, for a variety of purposes. FDA commissioner Marty Makary assuaged industry’s privacy concerns by promising ...
A breakthrough in AI breast cancer detection technology has been approved by the FDA. The tech company, “Clairity,” is responsible for the first FDA-approved AI platform that helps predict a woman’s ...
An agile, transparent, and ethics-driven oversight system is needed for the U.S. Food and Drug Administration (FDA) to balance innovation with patient ...
13d
InvestorsHub on MSNHyperfine Gains FDA Clearance for Next-Gen Optive AI Imaging SoftwareHyperfine, Inc. (NASDAQ: HYPR), the company behind the world’s first FDA-cleared portable MRI system powered by artificial ...
Vargas added, “We have already integrated an exclusive license for four algorithms into our Vision ... in low-regulation markets where Vision AI operates as a screening tool, and simultaneous progress ...
Health Affairs' Jeff Byers welcomes Senior Editor Michael Gerber back to the program to discuss the Food and Drug ...
Cardiosense, a medical AI company transforming cardiovascular disease management, today announced the launch of SEISMIC-HF II, a nationwide study to validate the company’s machine learning algorithm ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results